MarketInOut Stock Screener Log In | Sign Up
 

Enzolytics Inc

OTC • Healthcare • Biotechnology • Quote as of 09/22/2026 13:42
Enzolytics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization2.42 mln
Float4,737 mln
Earnings Date08/20/2026

Relative Strength

8 / 100
Severely lagging

ROE

0.16
Very low

ROA

-705
Deeply negative

Business Description

Enzolytics Inc. is a Texas-based company working to bring new treatments to patients suffering from serious infectious diseases. The company holds patents on therapies designed to fight HIV, as well as a unique process for creating human antibodies that attack and disable the virus without harmful side effects. These antibody-based treatments have been tested in clinical settings and are produced using the company's own specialized cell line.

Key Fundamentals

EPS-1.25
ROE0.16
RPS0.22
ROIC0.14
ROA-705
Interest Cover-8.97
EBITDA, mln-0.89
EV / EBITDA-0.26
Revenue, mln0.05
EV / Revenue4.89

Quote Details

Last 0.0004
Change -0.0001 (-20%)
Open 0.0003
Volume 16,319,298
Turnover 6,527.72
Average Volume 4,943,528

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 52 / 100   
1 Month -33.33% 5 / 100   
2 Months -55.56% 6 / 100   
6 Months 33.33% 82 / 100   
1 Year 100% 89 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us